These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 12732243

  • 1. Differential regulation of corticosteroid receptors by monoamine neurotransmitters and antidepressant drugs in primary hippocampal culture.
    Lai M, McCormick JA, Chapman KE, Kelly PA, Seckl JR, Yau JL.
    Neuroscience; 2003; 118(4):975-84. PubMed ID: 12732243
    [Abstract] [Full Text] [Related]

  • 2. Buspirone modulates basal and fluoxetine-stimulated dialysate levels of dopamine, noradrenaline and serotonin in the frontal cortex of freely moving rats: activation of serotonin1A receptors and blockade of alpha2-adrenergic receptors underlie its actions.
    Gobert A, Rivet JM, Cistarelli L, Melon C, Millan MJ.
    Neuroscience; 1999; 93(4):1251-62. PubMed ID: 10501449
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.
    Orús L, Pérez-Silanes S, Oficialdegui AM, Martínez-Esparza J, Del Castillo JC, Mourelle M, Langer T, Guccione S, Donzella G, Krovat EM, Poptodorov K, Lasheras B, Ballaz S, Hervías I, Tordera R, Del Río J, Monge A.
    J Med Chem; 2002 Sep 12; 45(19):4128-39. PubMed ID: 12213056
    [Abstract] [Full Text] [Related]

  • 4. 5-HT1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats.
    Moser PC, Sanger DJ.
    Eur J Pharmacol; 1999 May 14; 372(2):127-34. PubMed ID: 10395092
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C, Seyfried CA.
    Psychopharmacology (Berl); 2014 Jun 14; 231(12):2547-58. PubMed ID: 24419272
    [Abstract] [Full Text] [Related]

  • 6. Regulation of central corticosteroid receptors following short-term activation of serotonin transmission by 5-hydroxy-L-tryptophan or fluoxetine.
    Sémont A, Fache M, Héry F, Faudon M, Youssouf F, Héry M.
    J Neuroendocrinol; 2000 Aug 14; 12(8):736-44. PubMed ID: 10929085
    [Abstract] [Full Text] [Related]

  • 7. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME, Cryan JF, Sullivan A, Dalvi A, Saucy B, Manning DR, Lucki I.
    J Pharmacol Exp Ther; 2002 Sep 14; 302(3):1220-7. PubMed ID: 12183683
    [Abstract] [Full Text] [Related]

  • 8. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J, Schreiber R, Melon C, Dalmus M, Jentzsch KR.
    Eur Neuropsychopharmacol; 2004 Dec 14; 14(6):487-95. PubMed ID: 15589388
    [Abstract] [Full Text] [Related]

  • 9. Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: relationship with spatial learning in young and aged rats.
    Yau JL, Olsson T, Morris RG, Meaney MJ, Seckl JR.
    Neuroscience; 1995 Jun 14; 66(3):571-81. PubMed ID: 7644021
    [Abstract] [Full Text] [Related]

  • 10. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA.
    Eur J Pharmacol; 2005 Mar 07; 510(1-2):49-57. PubMed ID: 15740724
    [Abstract] [Full Text] [Related]

  • 11. Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones.
    Okugawa G, Omori K, Suzukawa J, Fujiseki Y, Kinoshita T, Inagaki C.
    J Neuroendocrinol; 1999 Nov 07; 11(11):887-95. PubMed ID: 10520140
    [Abstract] [Full Text] [Related]

  • 12. Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors.
    Tordera RM, Monge A, Del Río J, Lasheras B.
    Eur J Pharmacol; 2002 May 03; 442(1-2):63-71. PubMed ID: 12020683
    [Abstract] [Full Text] [Related]

  • 13. Chronic antidepressant treatments decrease pro-opiomelanocortin mRNA expression in the pituitary gland: effects of acute stress and 5-HT(1A) receptor activation.
    Jensen JB, Mørk A, Mikkelsen JD.
    J Neuroendocrinol; 2001 Oct 03; 13(10):887-93. PubMed ID: 11679057
    [Abstract] [Full Text] [Related]

  • 14. Hippocampal Bcl-2 expression is selectively increased following chronic but not acute treatment with antidepressants, 5-HT(1A) or 5-HT(2C/2B) receptor antagonists.
    Murray F, Hutson PH.
    Eur J Pharmacol; 2007 Aug 13; 569(1-2):41-7. PubMed ID: 17582397
    [Abstract] [Full Text] [Related]

  • 15. The hypotensive effect of BMY 7378 is antagonized by a silent 5-HT(1A) receptor antagonist: comparison with 8-hydroxy-dipropylamino tetralin.
    Villalobos-Molina R, López-Guerrero JJ, Ibarra M.
    Arch Med Res; 2001 Aug 13; 32(5):389-93. PubMed ID: 11578753
    [Abstract] [Full Text] [Related]

  • 16. Effects of flesinoxan on corticosteroid receptor expression in the rat hippocampus.
    Sibug RM, Compaan JC, Meijer OC, Van der Gugten J, Olivier B, De Kloet ER.
    Eur J Pharmacol; 2000 Sep 15; 404(1-2):111-9. PubMed ID: 10980269
    [Abstract] [Full Text] [Related]

  • 17. Effect of chronic fluoxetine and WAY-100635 treatment on serotonergic neurotransmission in the frontal cortex.
    Dawson LA, Nguyen HQ, Smith DL, Schechter LE.
    J Psychopharmacol; 2002 Jun 15; 16(2):145-52. PubMed ID: 12095073
    [Abstract] [Full Text] [Related]

  • 18. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ, Newman-Tancredi A, Rivet JM, Brocco M, Lacroix P, Audinot V, Cistarelli L, Gobert A.
    J Pharmacol Exp Ther; 1997 Jul 15; 282(1):132-47. PubMed ID: 9223549
    [Abstract] [Full Text] [Related]

  • 19. Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition.
    Guptarak J, Sarkar J, Hiegel C, Uphouse L.
    Horm Behav; 2010 Jul 15; 58(2):290-6. PubMed ID: 20223238
    [Abstract] [Full Text] [Related]

  • 20. Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-HT1B receptors.
    Gobert A, Millan MJ.
    Neuropsychopharmacology; 1999 Aug 15; 21(2):268-84. PubMed ID: 10432475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.